New Research Released on Avivagen Inc. (VIV-TSX.V)

Posted by Karen Goldfarb

March 7, 2017 at 12:41 PM

An Executive Informational Overview (EIO) is now available on pharmaceutical company, Avivagen Inc. (VIV-TSX.V). The EIO is a 56-page report detailing Avivagen's business, product development, strategic relationships, market opportunities, competition, financials, risks, and more. It is available for download below.

Download Avivagen Report

Read More
Content not found
Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Date

see all

Posts by Topic